• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Neuroendocrine differentiation and markers of cell proliferation in a group of patients with prostate adenocarcinoma and normal or high serum prostate-specific antigen levels].

作者信息

Feria-Bernal Guillermo, García-Gonzalez Victor Manuel, Figueroa-Granados Víctor, Martinez-Benítez Braulio, Uribe-Uribe Norma Ofelia

机构信息

Departamento de Urologia, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México D.F., México.

出版信息

Gac Med Mex. 2006 Nov-Dec;142(6):441-6.

PMID:17201105
Abstract

OBJECTIVE

Study the morphologic characteristics of neuroendocrine cells in prostate cancer with normal versus elevated prostate specific antigen (PSA).

MATERIALS AND METHODS

372 cases of prostate cancer were identified during a 13 year period, of which 19 displayed normal PSA (group I). Sixteen controls with elevated PSA and similar histopathological characteristics (group II) were included. We studied the degree of tumor necrosis, vascular and perineural invasion. Synaptophysin (SP), neuron specific enolase (NSE), PSA, Ki-67 and p53 inmunoreactivity were also analyzed.

RESULTS

Group I positive findings were 61% PSA, 28.6% SP. 7.1% NSE, 50%p53, and 78.6% Ki-67. Group II positive findings were 93% PSA, 13.3% SP, 26.6% NSE 46.6% p53, and 66.7% Ki-67. When we used a <80% cut off point for PSA immunoreactivity in tumor cells, 69.2% of group I and 21.4% of group II were found.

CONCLUSIONS

The sole histopathological finding that showed statistical significance was the tissular expression of the specific prostatic antigen in 80% of neoplasic cells in group I. The increase of neuroendocrine cells was associated with a smaller number of tissular antigen producing cells, a finding that could be more apparent if we were to study a larger sample size.

摘要

相似文献

1
[Neuroendocrine differentiation and markers of cell proliferation in a group of patients with prostate adenocarcinoma and normal or high serum prostate-specific antigen levels].
Gac Med Mex. 2006 Nov-Dec;142(6):441-6.
2
The chromogranin-A (CgA) in prostate cancer.前列腺癌中的嗜铬粒蛋白A(CgA)。
Arch Gerontol Geriatr. 2006 Jul-Aug;43(1):117-26. doi: 10.1016/j.archger.2005.09.008. Epub 2005 Nov 8.
3
Distribution of high chromogranin A serum levels in patients with nonmetastatic and metastatic prostate adenocarcinoma.非转移性和转移性前列腺腺癌患者血清嗜铬粒蛋白A水平的分布情况
Urol Int. 2009;82(2):147-51. doi: 10.1159/000200789. Epub 2009 Mar 19.
4
Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor.
Anticancer Res. 1994 Sep-Oct;14(5B):2151-6.
5
Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.前列腺特异性抗原半衰期与治疗前前列腺特异性抗原:延迟联合雄激素阻断治疗中前列腺特异性抗原变化趋势的关键预测因素
Int J Urol. 2007 Mar;14(3):192-6; discussion 197. doi: 10.1111/j.1442-2042.2007.01671.x.
6
Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.血清抗p53抗体在前列腺癌检测中的临床应用:与前列腺特异性抗原参数的比较研究
J Urol. 2004 Jan;171(1):182-6. doi: 10.1097/01.ju.0000101501.54931.4a.
7
Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.前列腺小细胞癌:95例的形态学和免疫组织化学研究
Am J Surg Pathol. 2008 Jan;32(1):65-71. doi: 10.1097/PAS.0b013e318058a96b.
8
[Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].[前列腺小细胞癌/腺癌合并:2例报告]
Hinyokika Kiyo. 2007 Jul;53(7):489-92.
9
Neuroendocrine differentiation in stage D2 prostate cancers.D2期前列腺癌中的神经内分泌分化
Int J Urol. 2008 May;15(5):423-8. doi: 10.1111/j.1442-2042.2008.02015.x.
10
Serum prostate-specific antigen and the biologic progression of prostate cancer.血清前列腺特异性抗原与前列腺癌的生物学进展
Urology. 1995 Jul;46(1):65-70. doi: 10.1016/S0090-4295(99)80161-7.